Abstract
The need for toxicological screening of amphetamine users is growing in parallel with its
increasing abuse. At the same time, it turns out that these substances most often give false results in
rapid drug immunoassay. Therefore, the aim of the present work was to investigate the sources of
false positive or false negative results. For this purpose, an analysis of the literature sources in the
databases of Google Scholar, PubMed, and Science Direct, was made. The results showed that a
number of prescription or OTC medications can cause false positive results due to cross-reactivity
(ephedrine, pseudoephedrine, labetalol, metoprolol, some antidepressants, metformin, ranitidine,
ofloxacin, selegiline, etc.). In this regard, alternative medications for patients who often have to undergo
such screening have been proposed. Some possibilities of unintentionally or intentionally inducing
false negative results have also been highlighted. Popular approaches to fooling the screening
test are diluting the urine, adding adulterants (marketed products or homemade chemicals), and
providing foreign or synthetic urine. Summarizing the possible sources of errors in drug screening is
expected to objectify the interpretation of the obtained results.
Keywords:
Amphetamines, immunoassay, cross-reactivity, false positive results, false negative results, psychostimulants.
Graphical Abstract
[9]
Spyres, M.B.; Jang, D.H. Amphetamines. In: Goldfrank’s Toxicologic Emergencies, 11th ed; Nelson, L.; Hoffman, R.; Howland, M.; Lewin, N.; Smith, S.W.; Goldfrank, L., Eds.; McGrow Hill: New York; , 2019, pp. 1099-1110.
[13]
Atanasov, V. Screening methods. Quantitative analysis. In: Forensic toxicology - principles and practice; Atanasov, V., Ed.; Military Medical Academy: Sofia, 2020, pp. 51-69.
[14]
McDermott, S.D. Drugs of Abuse. In: Clarke’s Analysis of Drugs
and Poisons, 4th ed; Moffat, A.; Osselton, D.; Widdop, B., Eds.; Pharmaceutical Press: London, 2011; pp. 190-207.
[17]
Yüksel, B.; Şen, N. Development and validation of a GC-FID method for determination of cocaine in illicit drug samples. Marmara Pharm. J., 2018, 22, 511-518.
[19]
Öncü, T.; Yüksel, B.; Binay, E.; Şen, N. Investigation of nitrosamine impurities in certain Sartan group medicinal products available in Istanbul Türkiye. Ann. Pharm. Fr., 2023, 2013.
[20]
Uges, D.R.A. Hospital toxicology.In: Clarke’s Analysis of Drugs and Poisons, 4th ed; Moffat, A.; Osselton, D.; Widdop, B., Eds.; Pharmaceutical Press: London; , 2011, pp. 3-58.
[23]
Koczula, K.M.; Gallotta, A. Lateral flow assays. In: Essays in Biochemistry; Koczula, K.M.; Gallotta, A., Eds.; Portland Press: London., 2016, 60, 111-120.
[37]
Schwebach, A.; Ball, J. Urine drug screening: Minimizing false-positives and false-negatives to optimize patient care. US Pharm., 2016, 41, 6-30.
[41]
Nomier, M.; Al-Huseini, H. False-positive TDxFLx urine amphetamine/metamphetamine II assay from Ofloxacin. SPJ, 2004, 12, 42-46.
[52]
Chou, S.L.; Giang, Y.S. Influences of seven Taiwan-produced adulterants on the fluorescence polarization immunoassay (FPIA) of amphetamines in urine. Forensic Sci. J., 2008, 7, 1-12.